Jonathan Meyer, MD: Round One
In part one of a two part interview, Craig Chepke, MD, discusses how new schizophrenia drugs in development pipeline are expected to change the therapeutic landscape with Jonathan Meyer, MD.
Moderator Craig Chepke, MD, conducts a series of investigative interviews with a fellow healthcare professional, exploring each aspect of schizophrenia from a new lens. A new topic will publish each month.
▶ 8 mins
▶ 13 mins
▶ 9 mins
▶ 11 mins
▶ 3 mins
▶ 3 mins
▶ 4 mins
